Literature DB >> 23801009

Worldwide epidemiology of fibromyalgia.

Luiz Paulo Queiroz1.   

Abstract

Studying the epidemiology of fibromyalgia (FM) is very important to understand the impact of this disorder on persons, families and society. The recent modified 2010 classification criteria of the American College of Rheumatology (ACR), without the need of tender points palpation, allows that larger and nationwide surveys may be done, worldwide. This article reviews the prevalence and incidence studies done in the general population, in several countries/continents, the prevalence of FM in special groups/settings, the association of FM with some sociodemographic characteristics of the population, and the comorbidity of FM with others disorders, especially with headaches.

Entities:  

Mesh:

Year:  2013        PMID: 23801009     DOI: 10.1007/s11916-013-0356-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  53 in total

1.  Prevalence of fibromyalgia and chronic widespread pain.

Authors:  L Lindell; S Bergman; I F Petersson; L T Jacobsson; P Herrström
Journal:  Scand J Prim Health Care       Date:  2000-09       Impact factor: 2.581

2.  Musculoskeletal pain in Malaysia: a COPCORD survey.

Authors:  Kiran Veerapen; Richard D Wigley; Hans Valkenburg
Journal:  J Rheumatol       Date:  2007-01       Impact factor: 4.666

3.  Fibromyalgia is common in patients with transformed migraine.

Authors:  M F Peres; W B Young; A O Kaup; E Zukerman; S D Silberstein
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

4.  The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  J Rheumatol       Date:  1999-07       Impact factor: 4.666

5.  Fibromyalgia comorbidity in primary headaches.

Authors:  M de Tommaso; M Sardaro; C Serpino; F Costantini; E Vecchio; M Pia Prudenzano; P Lamberti; P Livrea
Journal:  Cephalalgia       Date:  2009-12-15       Impact factor: 6.292

6.  Migraine comorbidity constellations.

Authors:  Gretchen E Tietjen; Nabeel A Herial; Jacqueline Hardgrove; Christine Utley; Leah White
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

7.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

8.  Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project.

Authors:  Ann Vincent; Brian D Lahr; Frederick Wolfe; Daniel J Clauw; Mary O Whipple; Terry H Oh; Debra L Barton; Jennifer St Sauver
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

9.  Prevalence of fibromyalgia in children: a clinical study of Mexican children.

Authors:  P Clark; R Burgos-Vargas; C Medina-Palma; P Lavielle; F F Marina
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

10.  Prevalence of fibromyalgia: a survey in five European countries.

Authors:  Jaime C Branco; Bernard Bannwarth; Inmaculada Failde; Jordi Abello Carbonell; Francis Blotman; Michael Spaeth; Fernando Saraiva; Francesca Nacci; Eric Thomas; Jean-Paul Caubère; Katell Le Lay; Charles Taieb; Marco Matucci-Cerinic
Journal:  Semin Arthritis Rheum       Date:  2009-02-27       Impact factor: 5.532

View more
  159 in total

1.  Perceived burdensomeness, thwarted belongingness and suicidal ideation in patients with fibromyalgia and healthy subjects: a cross-sectional study.

Authors:  Cristina P Lafuente-Castro; Jorge L Ordoñez-Carrasco; Juan M Garcia-Leiva; Monika Salgueiro-Macho; Elena P Calandre
Journal:  Rheumatol Int       Date:  2018-06-01       Impact factor: 2.631

Review 2.  The role of sleep in pain and fibromyalgia.

Authors:  Ernest H S Choy
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

3.  The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial.

Authors:  Ilknur Saral; Dilsad Sindel; Sina Esmaeilzadeh; Hanife Ozlem Sertel-Berk; Aydan Oral
Journal:  Rheumatol Int       Date:  2016-04-07       Impact factor: 2.631

4.  Fibromyalgia in Behçet's disease: a narrative review.

Authors:  Claire Jobanputra; Roberta H Richey; Jagdish Nair; Robert J Moots; Andreas Goebel
Journal:  Br J Pain       Date:  2017-03-22

5.  Low-level laser therapy combined to functional exercise on treatment of fibromyalgia: a double-blind randomized clinical trial.

Authors:  Daniel Germano Maciel; Marianne Trajano da Silva; José Antônio Rodrigues; João Batista Viana Neto; Ingrid Martins de França; Ana Beatriz Medeiros Melo; Therence Yves Pereira Barros da Silva; Wouber Hérickson de Brito Vieira
Journal:  Lasers Med Sci       Date:  2018-06-21       Impact factor: 3.161

6.  Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators.

Authors:  C Rusu; M E Gee; C Lagacé; M Parlor
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-03       Impact factor: 3.240

7.  Exposure to Cold Unmasks Potential Biomarkers of Fibromyalgia Syndrome Reflecting Insufficient Sympathetic Responses to Stress.

Authors:  José V Pardo; Robert C Larson; Rachel J Spencer; Joel T Lee; Jeffrey D Pasley; Carolyn J Torkelson; Alice A Larson
Journal:  Clin J Pain       Date:  2019-05       Impact factor: 3.442

Review 8.  [Musculoskeletal-related chest pain].

Authors:  C Sturm; T Witte
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

Review 9.  Milnacipran for pain in fibromyalgia in adults.

Authors:  Malene Cording; Sheena Derry; Tudor Phillips; R Andrew Moore; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2015-10-20

10.  To walk or not to walk: insights from a qualitative description study with women suffering from fibromyalgia.

Authors:  Yolanda Sanz-Baños; María-Ángeles Pastor; Lilian Velasco; Sofía López-Roig; Cecilia Peñacoba; Ana Lledo; Charo Rodríguez
Journal:  Rheumatol Int       Date:  2016-03-15       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.